Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Alix O'Meara Stern"'
Autor:
Dominik Menges, Michela C. Piatti, Aurelius Omlin, Richard Cathomas, Daniel Benamran, Stefanie Fischer, Christophe Iselin, Marc Küng, Anja Lorch, Lukas Prause, Christian Rothermundt, Alix O'Meara Stern, Deborah Zihler, Max Lippuner, Julia Braun, Thomas Cerny, Milo A. Puhan
Publikováno v:
European Urology Open Science, Vol 51, Iss , Pp 26-38 (2023)
Background: Patient preferences for treatment outcomes are important to guide decision-making in clinical practice, but little is known about the preferences of patients with metastatic hormone-sensitive prostate cancer (mHSPC). Objective: To evaluat
Externí odkaz:
https://doaj.org/article/e0c1e180eac24f009c233291a5887f69
Publikováno v:
Frontiers in Medicine, Vol 10 (2023)
Abiraterone acetate is a steroidal inhibitor of cytochrome P450 17A1 indicated in the treatment of metastatic prostate cancer. This report examines the case of a 66-year-old patient diagnosed with prostate adenocarcinoma that had metastasized to the
Externí odkaz:
https://doaj.org/article/fae77511289c47ddb38fe3a08564b979
Autor:
Anna Petropoulou, Alix O’Meara Stern, Sabine Gerull, Nicolas Leuthold, Marco E. G. V. Cattaneo, Claudia Hügli, Monika Kirsch, Tobias E. Erlanger, Jakob Passweg, Jörg Halter
Publikováno v:
Supportive Care in Cancer
Oncological studies have shown that patients consider small benefits sufficient to make adjuvant chemotherapy worthwhile. We sought to determine the minimal survival benefits that patients considered enough to legitimate allogeneic haematopoietic ste
Autor:
Martin Andres, Michael Baumann, Davide Rossi, Urban Novak, Georg Stussi, Yves Chalandon, Thomas Pabst, Ulrich Mey, Rudolf Benz, Jakob Passweg, Qiyu Li, Elena Bianchi-Papina, Anita Feller, Simona Berardi, Nathan Cantoni, Sabine Blum, Andreas Lohri, Mario Bargetzi, Daniel Rauch, Urs Hess, Felicitas Hitz, Reinhard Zenhaeusern, Alix O’Meara Stern, Kornelius Arn
Publikováno v:
Blood Adv
Blood Advances, Vol. 4, No 15 (2020) pp. 3699-3707
Blood Advances, Vol. 4, No 15 (2020) pp. 3699-3707
Hairy cell leukemia (HCL) remains an incurable disease. However, first-line treatment with either intravenous or subcutaneous cladribine generally leads to long-lasting remissions. Although there are excellent long-term data for intravenous applicati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::675d4cfcb80346d1273a1c4304abe7d3
Autor:
Alexandra Plattner, Michael Medinger, Alix O’Meara Stern, Jakob Passweg, Dominik Heim, Jörg Halter, Rebekka Plattner, Laura Infanti, Christoph Bucher, Andreas Buser, Martina Kleber, Claude Rothen, Nadine Schmidlin, Andreas Holbro
Publikováno v:
Bone marrow transplantation. 54(2)